Topic: Global Brands Inc.

FDA Approves Watson's Androderm 2 mg/day and 4 mg/day

Benzinga.com - 119 days ago
Posted on 10/21/11 at 7:55am by Eddie Staley . Watson Pharmaceuticals, Inc. (NYSE: WPI ) today announced that the U.S. Food and Drug Administration...

Calls Purchased on Watson Pharmaceut...

Benzinga.com - 269 days ago
Posted on 05/25/11 at 1:08pm by Michael J. Zerinskas . Shares of Watson Pharmaceuticals, Inc. (NYSE: WPI ) are higher on the session by 0.63%...

JWT Brings BrandZ Data to Life With the Launch of Brand Toys, the World's First Brand Visualization Tool

American Banking News - 285 days ago
JWT Brings BrandZ Data to Life With the Launch of Brand Toys, the World's First Brand Visualization Tool. . JWT has launched Brand Toys, the...

Calls Purchased on Watson Pharmaceuticals (WPI)

Benzinga.com - 318 days ago
Posted on 04/06/11 at 10:40am by Michael J. Zerinskas . Shares of Watson Pharmaceuticals (NYSE: WPI ) are higher on the session by 1.07%, currently...

Watson Announces Approval of Nulecit, the First Generic Alternative to Ferrlecit for the Treatment of Iron Deficiency Anemia

Benzinga.com - 323 days ago
Posted on 03/31/11 at 1:56pm by Benzinga Staff . Watson Pharmaceuticals, Inc. (NYSE: WPI ) today announced that it is initiating launch activities ...

Watson Sees 2011 EPS of $3.85 to $4.15

Benzinga.com - 393 days ago
During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. (NYSE: WPI ) provided an update on its Global businesses...

Watson Pharmaceuticals: Looking Ahead to December 2010 Quarterly Results

SeekingAlpha - 414 days ago
This post describes our model of Watson Pharmaceuticals' (NYSE: WPI) Income Statement for 2010's fourth quarter, which ends today. . The purpose of...

Watson Q3 Net Revenue Climbs 33 Percent to $882 Million

Drugs.com - 471 days ago
Third Quarter Adjusted Cash EPS of $0.85 - Adjusted EBITDA Increases 18 Percent to $211 Million . Adjusted EBITDA increased 18 percent to $211.1 million for the third quarter 2010, versus $178.4 million for the third quarter 2009. In our Global ...

Watson Q2 Net Revenue Climbs 29 Percent to $875 Million

Drugs.com - 562 days ago
Second Quarter Adjusted Cash EPS of $0.83; 2010 GAAP EPS of $0.57 - Adjusted EBITDA Increases 26 Percent to $207 Million. GAAP earnings for the second quarter 2010 were $0.57 per share, compared to $0.46 per share in the ...

Bacardi names Silvia Lagnado new marketing head

AP News - 632 days ago
Bacardi appoints former Unilever exec Silvia Lagnado chief marketing officerSpirits maker Bacardi Limited has appointed Silvia Lagnado chief marketing officer and president of Bacardi Global Brands.Lagnado, 46, joins the privately-held company after 24 years at Unilever, effective Sept. 1. She will ...